Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism
Genes · 2024
DOI: 10.3390/genes15060804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Yogapriya Sundaresan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel. Hauptthemen laut MEDLINE: Mutation, Retinitis Pigmentosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Israel Ministry of Health, Foundation Fighting Blindness.
Abstract (Originalsprache)
Retinitis pigmentosa (RP) is a heterogeneous inherited retinal disorder. Mutations in KIZ cause autosomal recessive (AR) RP. We aimed to characterize the genotype, expression pattern, and phenotype in a large cohort of KIZ cases. Sanger and whole exome sequencing were used to identify the KIZ variants. Medical records were reviewed and analyzed. Thirty-one patients with biallelic KIZ mutations were identified: 28 homozygous for c.226C>T (p.R76*), 2 compound heterozygous for p.R76* and c.3G>A (p.M1?), and one homozygous for c.247C>T (p.R83*). c.226C>T is a founder mutation among patients of Jewish descent. The clinical parameters were less severe in KIZ compared to DHDDS and FAM161A cases. RT-PCR analysis in fibroblast cells revealed the presence of four different transcripts in both WT and mutant samples with a lower percentage of the WT transcript in patients. Sequence analysis identified an exonic sequence enhancer (ESE) that includes the c.226 position which is affected by the mutation. KIZ mutations are an uncommon cause of IRD worldwide but are not rare among Ashkenazi Jews. Our data indicate that p.R76* affect an ESE which in turn results in the pronounced skipping of exon 3. Therefore, RNA-based therapies might show low efficacy since the mutant transcripts are spliced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
- Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
- Ophthalmology Division, Tel Aviv Sourasky Medical Center, Affiliated to Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
- Department of Ophthalmology, Rambam Health Care Center, Haifa 31096, Israel.
- Department of Ophthalmology, Rabin Medical Center, Petah Tikva 49100, Israel.
- The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.
ORCID-Profile: Ron Ofri, Shiri Soudry, Dinah Zur, Dror Sharon
Förderung
- Israel Science Foundation
- Israel Ministry of Health
- Foundation Fighting Blindness
- Israeli Ministry of Health
Zitieren
APA
Sundaresan, Y., Rivera, A., Obolensky, A., Gopalakrishnan, P., Ohayon Hadad, H., Shemesh, A., Khateb, S., Ross, M., Ofri, R., Durst, S., Newman, H., Leibu, R., Soudry, S., Zur, D., Ben-Yosef, T., Banin, E., & Sharon, D. (2024). Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism. Genes. https://doi.org/10.3390/genes15060804
Vancouver
Sundaresan Y, Rivera A, Obolensky A, Gopalakrishnan P, Ohayon Hadad H, Shemesh A, et al. Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism. Genes. 2024. doi:10.3390/genes15060804
BibTeX
@article{Sundaresan2024,
author = {Sundaresan, Yogapriya and Rivera, Antonio and Obolensky, Alexey and Gopalakrishnan, Prakadeeswari and Ohayon Hadad, Hanit and Shemesh, Aya and Khateb, Samer and Ross, Maya and Ofri, Ron and Durst, Sharon and Newman, Hadas and Leibu, Rina and Soudry, Shiri and Zur, Dinah and Ben-Yosef, Tamar and Banin, Eyal and Sharon, Dror},
title = {Genetic and Clinical Analyses of the KIZ-c.226C>T Variant Resulting in a Dual Mutational Mechanism},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15060804}
}
EUVIMED